Walter Strapps of Idera to speak at Nucleic Acid R & D Meeting, June 19&20, 2014, San Diego, CA.
Walter R. Strapps, Executive Director of RNA Therapeutics at Idera Pharmaceuticals, Inc., to give a presentation titled "Gene Silencing Oligos The Next Generation in Gene Silencing"
SAN DIEGO, CA, April 02, 2014
Walter R. Strapps, Executive Director of RNA Therapeutics at Idera Pharmaceuticals, Inc., to give a presentation titled "Gene Silencing Oligos: The Next Generation in Gene Silencing" at the Inaugural Nucleic Acid Research and Development Conference, June 29 & 20, 2014 in San Diego, CA.Dr. Strapps leads the RNA Discovery unit at Idera and is responsible for research and development of Idera's gene silencing oligo (GSO) platform. Dr. Strapps joined Idera in 2014. Prior to Idera, Dr. Strapps was Director, RNAi Therapeutics at Merck & Co., Inc. where he led siRNA lead identification and lead optimization efforts. Dr. Strapps holds a B.Sc. in Biology from McGill University and an M.A., M.Phil and Ph.D. in Genetics and Development from Columbia University.
Dr. Strapps talk will discuss:
• A unique oligonucleotide platform with two linked single strands
• Structure mitigates concerns and improves upon antisense
• Investigation into SAR provides opportunities for further optimization
For more information, please visit http://www.gtcbio.com/nucleicacid/agenda
GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.
GTC (Global Technology Community), LLC, is a privately held company founded in 2002.